# Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis

> **NCT01427738** · PHASE3 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 221 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Gentian Violet
- **DRUG:** Nystatin oral suspension

## Key facts

- **NCT ID:** NCT01427738
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-09
- **Final completion:** 2014-01
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2015-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427738, "Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01427738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*